XILLIX FDA APPROVED Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XILLIX FDA APPROVED

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jeffrey P. Sponseller who wrote (296)	8/27/1998 12:24:00 AM
From: Garry K.	Read Replies (1) of 572

You are right about the many applications of the endoscope, and how often it is used for the diagnosis and detection of many different diseases. Using Xillix's technology for the early detection of lung cancer (bronchoscopy) is just the tip of the iceberg... the estimate for the market potential of the LIFE-GI system is estimated to be 4 times the size of the bronchoscopy market. Then there is the ENT system (ear, nose and throat), as well as the GYN system for cervical cancers. There are many applications for this technology for the localization of many different cancers. There are around 5,000 institutions worldwide that already use white-light bronchoscopes, with 1,000 hospitals in the developed world that specialize in cancer. And with Olympus owning 70% of this market, Xillix should have a receptive market once the products have cleared the final stages of development. This will take time, but it IMO it will be worth the wait for those with patience. Good luck! Garry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next